Should Children With Acute Asthma Exacerbation Receive Inhaled Anticholinergics?
dc.contributor.author | Cooper, Dylan D. | |
dc.contributor.author | Welch, Julie L. | |
dc.contributor.department | Department of Emergency Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2015-12-21T19:39:23Z | |
dc.date.available | 2015-12-21T19:39:23Z | |
dc.date.issued | 2015-01 | |
dc.description.abstract | The use of inhaled anticholinergics (ipratropium bromide) along with inhaled short-acting β-agonists (albuterol) can reduce hospital admission rates in children with moderate to severe asthma exacerbations. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Cooper, D. D., & Welch, J. L. (2015). Should Children With Acute Asthma Exacerbation Receive Inhaled Anticholinergics? Annals of Emergency Medicine, 65(1), 83–84. http://doi.org/10.1016/j.annemergmed.2014.06.014 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/7784 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.annemergmed.2014.06.014 | en_US |
dc.relation.journal | Annals of Emergency Medicine | en_US |
dc.rights | IUPUI Open Access Policy | en_US |
dc.source | Author | en_US |
dc.subject | asthma | en_US |
dc.subject | anticholinergics | en_US |
dc.subject | ipratropium bromide | en_US |
dc.subject | albuterol | en_US |
dc.title | Should Children With Acute Asthma Exacerbation Receive Inhaled Anticholinergics? | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- cooper-2015-should-children.pdf
- Size:
- 118.9 KB
- Format:
- Adobe Portable Document Format
- Description:
- Author's manuscript
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.88 KB
- Format:
- Item-specific license agreed upon to submission
- Description: